Medtronic brought in revenues of $8.3bn for the quarter, up 2.5% from the same period in 2024. Image credit: Shutterstock / JHVEPhoto. Medtronic posted a strong profit for Q3 of fiscal year 2025, ...

Medtronic reported 7% growth in U.S. core spine and biologics in its most recent quarterly results. The company attributed the growth to its creation of a portfolio of spine implants and enabling ...

Medtronic posted a strong profit for Q3 of fiscal year 2025, though shares were down as its cardiac ablation product success was offset by weaker sales from its medical-surgical business.

Medtronic Q3 revenue ... increase in Cranial & Spinal Technologies, and low-single-digit increase in Specialty Therapies, all on an organic basis. Medical Surgical revenue of $2.07 billion ...

NEW YORK, Feb. 25, 2025 /PRNewswire/ -- Surgical Safety Technologies proudly announces its support for an innovative collaboration between the Mount Sinai Global Surgery Program and Kyabirwa ...

Medtronic announced on Monday that the Food and Drug Administration approved its BrainSense Adaptive deep brain stimulation technology and BrainSense Electrode Identifier to treat Parkinson’s ...

The company, whose products range from insulin pumps to surgical robots ... ways to optimize our manufacturing footprint," Medtronic's Chief Technology Officer Ken Washington said on the sidelines ...

Medtronic is nearing a U.S. launch for its Hugo surgical robot more than three years after receiving approval to release the soft tissue system in Europe. CEO Geoff Martha told investors Tuesday that ...

FDA-Cleared Nanotechnology developed by Nanovis is planned for use to enhance Medtronic PEEK interbody fusion devices used in Spine Surgery. Press Release: MTI Staff was not involved in writing this ...

After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive technology personalizing treatment of Parkinson’s symptoms using advanced ...